Precision Optics to Present at Lytham Partners Investor Select Conference on January 31st
Precision Optics Corporation (NASDAQ: POCI) announced that CEO Dr. Joe Forkey will present at the Lytham Partners Investor Select Conference on January 31, 2023. The event will take place virtually, allowing for one-on-one meetings with investors. Attendees can view the company's webcast presentation at 9:00 AM ET on the same day via the company's website or through the provided webcast link. Precision Optics specializes in designing and manufacturing advanced optical instruments for the medical and defense industries and has significant expertise in micro-optics and 3D imaging technologies.
- None.
- None.
Company Webcast
The Company's webcast presentation will be available for viewing at
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements which express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company's annual report on Form 10-K and in other documents we file from time to time with the
Company Contact:
PRECISION OPTICS CORPORATION
Telephone: 978-630-1800
Investor Contact:
Telephone: 602-889-9700
poci@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/precision-optics-to-present-at-lytham-partners-investor-select-conference-on-january-31st-301732134.html
SOURCE Precision Optics Corporation